PD-1阻断在前列腺癌中一再失利。
PD-1 Blockade Falls Short (Repeatedly) in Prostate Cancer.
发表日期：2023 Mar 16
作者：
来源：
Cancer Discovery
摘要：
评估PD-1抑制剂Pembrolizumab在男性前列腺癌晚期试验中的所有失败，导致临床医生得出结论，需要新的治疗策略来帮助使得检查站阻滞在大多数前列腺肿瘤的免疫抑制环境中更有效。 ©2023美国癌症研究协会。
Late-stage trials evaluating the PD-1 inhibitor pembrolizumab in men with prostate cancer have all ended in failure, leading clinicians to conclude that new treatment strategies are needed to help make checkpoint blockade more effective in the immune-suppressed environment of most prostate tumors.©2023 American Association for Cancer Research.